CopyPastehas never been so tasty!

Access Pharmaceuticals, Inc. (ACCP) - Financial and Strategi

by anonymous

  • 0
  • 0
  • 0
584 views added a new company report " Access Pharmaceuticals, Inc. (ACCP) - Financial and Strategic SWOT Analysis Review " which gives in depth information and data about the company and its operations.

Access Pharmaceuticals, Inc., a biopharmaceutical company. It develops novel therapeutics for the treatment of cancer and supportive care of cancer patients. The company’s products include MuGard for the management of patients with mucositis; and ProLindac, a nanopolymer DACH-platinum prodrug that is in Phase II clinical trial for the treatment of ovarian cancer. It also has other advanced drug delivery technologies, such as CobaCyte-mediated targeted delivery technology and CobOral, a preclinical nanopolymer oral drug delivery technology based on the natural vitamin B12 oral uptake mechanism. The company has a collaborative agreement with RNAi industry to develop CobaCyte and CobOral technology for the delivery of RNAi therapeutics. Access Pharmaceuticals, headquartered in Dallas, Texas.

Access Pharmaceuticals, Inc. Key Recent Developments

Nov 14, 2012 Access Pharma Reports Q3 2012 Results
Aug 14, 2012 Access Pharma Reports Q2 2012 Results
May 15, 2012 Access Pharma Reports Revenue Of $1.9m In Q1 2012
Mar 23, 2012 Access Pharma Reports Revenue Of $1.8m In 2011

This comprehensive SWOT profile of Access Pharmaceuticals, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Table of Contents 2
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Access Pharmaceuticals, Inc. - Key Facts 5
Access Pharmaceuticals, Inc. - Key Employees 6
Access Pharmaceuticals, Inc. - Key Employee Biographies 7
Access Pharmaceuticals, Inc. - Major Products and Services 8
Access Pharmaceuticals, Inc. - Pharmaceutical Pipeline Products Data 9
Access Pharmaceuticals, Inc., Pipeline Products by Therapy Area 9
Access Pharmaceuticals, Inc., Pipeline Products by Development Phase 10
Access Pharmaceuticals, Inc. - History 12
Access Pharmaceuticals, Inc. - Company Statement 14
Access Pharmaceuticals, Inc. - Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Section 2 – Company Analysis 17
Access Pharmaceuticals, Inc. - Business Description 17
Access Pharmaceuticals, Inc. - SWOT Analysis 18
SWOT Analysis - Overview 18
Access Pharmaceuticals, Inc. - Strengths 18
Strength - Drug Delivery Technologies 18
Strength - Research and Development activities 18
Strength - Strong Patent Portfolio 18
Access Pharmaceuticals, Inc. - Weaknesses 18
Weakness - Negative Profitability 18
Access Pharmaceuticals, Inc. - Opportunities 19
Opportunity - Strategic Agreements 19
Opportunity - Potential Mucositis Market 19

For more information kindly visit:


Contact Us at :

Company Profiles and Conferences
Tel: +919223375060 / 919223767111
Fax : +91 22 27810778


Add A Comment: